Skip to main content
NIH funding notice PAR-25-275

Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closed on February 28, 2025.

Posted
November 19, 2024
Close date
February 28, 2025
Activity codes
U01
Institutes taking part
NCI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: PAR-22-162 Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Replaced by PAR-27-073.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,997,626 in first-year total cost, median $881,405.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RTRB-Z (O2)]1
  2. Special Emphasis Panel[ZCA1 TCRB-5 (J1)]1
  3. Special Emphasis Panel[ZCA1 TCRB-5 (O1)]1
  4. Special Emphasis Panel[ZCA1 TCRB-9 (J2)]1
  5. Special Emphasis Panel[ZCA1 TCRB-V (J1)]1

Most frequent institutions

  1. KAISER FOUNDATION RESEARCH INSTITUTE1
  2. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
  3. RHODE ISLAND HOSPITAL1
  4. ST. JUDE CHILDREN'S RESEARCH HOSPITAL1
  5. UNIVERSITY OF SOUTHERN CALIFORNIA1
Competing awards under PAR-25-275 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025The St. Jude Lifetime Cohort Study1U01CA301480-01 · under PAR-22-162HUDSON, MELISSA MNESS, KIRSTEN KIMBERLIEST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN$1,059,908ZCA1
2025A prospective study of circulating autoantibodies and breast cancer risk in the NYU Women’s Health Study1U01CA290680-01A1 · under PAR-22-162CHEN, YUNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$703,423ZCA1
2024Identifying factors associated with prostate cancer progression and survival in African American men: The RESPOND Cohort1U01CA287036-01A1 · under PAR-22-162HAIMAN, CHRISTOPHER ALANUNIVERSITY OF SOUTHERN CALIFORNIA, CA$1,620,203ZCA1
2024The COVID-19 and Cancer Consortium (CCC19) Registry1U01CA287008-01 · under PAR-22-162REID, SONYAWARNER, JEREMY LYLERHODE ISLAND HOSPITAL, RI$732,687ZCA1
2023Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer1U01CA280991-01 · under PAR-22-162KWAN, MARILYN LTANG, LIKAISER FOUNDATION RESEARCH INSTITUTE, CA$881,405ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-25-275: Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience